Many of the iatrogenic events as mentioned above induce increased expression of inflammatory cytokines due to activation of NF-??B and/or AP-1, and in a preferred embodiment provided is a method wherein translocation and/or activity of the NF-kappaB/Rel protein or AP-1 protein is inhibited.